Skip to site menu Skip to page content

TrialHub

Patient Feasibility Platform to Empower Clinical Trial Strategists

TrialHub is an AI-powered platform designed to aid the clinical trial planning process by increasing access to patient insights.

Subscribed

You have successfully submitted your enquiry. Someone from our company will respond ASAP

About Us

Company social media

TrialHub empowers clinical research via a 360-degree feasibility suite that builds on generative AI to provide instant access to real-time, peer-reviewed scientific databases. With our AI-powered chat, epidemiology-level intelligence and detailed patient insights, clinical trial strategists can plan a trial from start to finish in a few clicks. TrialHub databases have been carefully verified by an international team of medical experts.

TrialHub IQ, our AI-based natural language search engine, transforms TrialHub into a knowledge hub for clinical research that connects to more than 80,000 data sources, as well as millions of peer-reviewed PubMed publications and medical guidelines. The service offers tools to help users identify and assess potential clinical trial sites, recruit patients, and better understand the local reimbursement landscape to help them plan successful patient-centric clinical trials.

Patient feasibility for successful recruitment and retention

TrialHub goes beyond the standard site and country feasibility data to ensure successful clinical trial recruitment. Users can benefit from deep patient understanding opportunities by performing a first-of-its-kind Patient Feasibility assessment.

Prevalence: identify countries with a large patient pool. Gain access to diverse as well as remote populations.
Competition: Create a competitive trial strategy by gaining insights on future competition projections
Past experience: check out locations with completed trials to identify sites with more experience in your indication and benefit from a friendly research infrastructure.
Recruitment rates: Identify countries with historically high recruitment rates in your indication. Meet the untapped patient needs in those countries by cross-referencing Recruitment Rates with Standard of Care
Standard of care: Identify countries where patients are more likely to need your trial by comparing your protocol to the local treatment.
Patient insights: generate highly accurate patient insights in a matter of seconds and design your trial strategy accordingly.

Patient Feasibility helps experts understand where their competitor drug is reimbursed and, as part of the local standard of care, locates eligible patients in countries where the patient pathway corresponds with their trial’s specific requirements. Integrating insights about reimbursement and utilising TrialHub’s AI-powered chat can effectively map out patients’ journey, illustrating their progression from initial symptoms to treatment.

In addition, TrialHub allows users to generate unique insights that are specific to their own needs by uploading their own proprietary data. For example, a user could upload their own unstructured patient data to generate insights into the feasibility of adapting a certain trial to the needs and preferences of patients in a certain region or population. This ultimately makes Patient Feasibility an essential process for ensuring the trial meets diversity and inclusion criteria.

Country and site selection for clinical trials

TrialHub’s Feasibility Index is a tool designed to optimise country selection by understanding the local landscape. It provides a map overview, enabling quick country comparisons using criteria such as epidemiology, competition, average recruitment rates, past experiences, and start-up timelines.

By offering a comprehensive view, the Feasibility Index prioritises target countries based on their potential. Users can also pinpoint locations where patients are most aligned with their trials by juxtaposing the trial protocols against local standard-of-care treatments.

To further assist users with site selection, TrialHub connects them with more than 100 local experts in its network, who can deliver unparalleled insights and remove the need for extra vendors.

Successful trials without delays or additional costs

To help ensure easier clinical trial planning, TrialHub allows users to identify and assess potential clinical trial sites that are most likely to recruit patients. This improves the efficiency and effectiveness of their protocols, reducing costs associated with clinical trials by avoiding costly mistakes, such as recruiting patients who are not eligible for the trial or selecting sites that do not have the necessary experience.

TrialHub enables you to generate unique insights by blending vast amounts of verified data sources with your own company data, putting you ahead of the competition.

Trusted feasibility platform for pharmaceutical industry leaders

TrialHub is a trusted partner of leading pharmaceutical and contract research companies such as Novartis, Medpace, ICON, Syneos, Veristat, Premier Research, ProTrials, Bionical Emas, PRC Clinical, and Avance Clinical. To date, TrialHub has been used for the planning of more than 6,000 trials and is praised for its highly accurate data, intuitive interface and outstanding customer support.

To learn more about TrialHub and its advantages, make an enquiry with us today via the form on this page.

Press Releases

Navigating Neurology Trials: How Avance Clinical Achieved Success with TrialHub's Precise Recruitment Rate Assessments

This case study details the strategic collaboration between Avance Clinical and TrialHub to secure a number of Phase I/II clinical trials in neurology sub-specialties. Avance Clinical leveraged TrialHub’s advanced data capabilities to deliver a proposal with unparalleled depth and specificity, resulting in not only being awarded the opportunity to partner, but also earning an additional study from the impressed client. The success showcases the critical role of precise, data-driven feasibility assessments in modern drug development.

TrialHub and Biomapas Announce Partnership to Drive Innovations in Clinical Trial Management

TrialHub, the pioneering data intelligence platform known for its innovative use of NLP and AI technologies in clinical trial management, is thrilled to announce a strategic partnership with Biomapas, a global provider of integrated clinical, regulatory, pharmacovigilance, and medical information services. This collaboration marks a significant step forward in enhancing clinical research methodologies and accelerating patient-centric trials.

Patient Empowerment in Clinical Trials: 1MEDs Partnership with FindMeCure’s TrialHub, Supports EUPATI's Educational Programme

In a landmark move underscoring its commitment to patient-centric healthcare solutions, 1MED has announced a scholarship donation to the European Patients’ Academy (EUPATI). This contribution is part of the partnership with FindMeCure and its innovative TrialHub platform. It aims to empower patients through education, making them pivotal contributors to clinical trial decision-making processes.

LINK Medical Partners with FindMeCure to Enhance Patient-Centric Research via EUPATI Scholarship Donation

LINK Medical, a Nordic leader in pharmaceutical and medical device development services, through a partnership with FindMeCure’s TrialHub, is supporting patient education with a scholarship donation to the European Patients’ Academy on Therapeutic Innovation (EUPATI). This initiative underlines LINK Medical’s commitment to patient-centric research, complementing FindMeCure's mission to enhance patient-centricity in clinical research with data-driven insights and patient feasibility.

Enhancing Patient Inclusion Through Partnership: Bionical Emas Joins FindMeCure & EUPATI

In the landscape of clinical research, patient inclusion has become a significant matter of focus. Contract research organisations (CROs) must prioritise collaboration with other stakeholders to improve clinical trials' quality and effectiveness. Through partnering with FindMeCure, the company behind the revolutionary data intelligence platform, TrialHub, Bionical Emas further supports patient inclusion in clinical research by donating a scholarship to the European Patients’ Academy on Therapeutic Innovation (EUPATI) patient education programme.

Indegene and FindMeCure’s TrialHub Partner to Enhance Patient Inclusion in Clinical Trials

Indegene, FindMeCure and European Patients’ Academy on Therapeutic Innovation (EUPATI) have joined hands to drive advancement and innovation in treatment practices through greater patient engagement in clinical research. By working with FindMeCure’s feasibility data intelligence platform, Indegene aims to further the cause of delivering affordable patient-centric care.

Videos

Syneos Health Testimonial

Thomas Christie from Syneos Health shares his company's story of working with TrialHub and the benefits they experienced as a result.

Bionical Emas Testimonial

Interview with pharmaceutical company Bionical Emas on their experience using TrialHub's clinical trial intelligence platform.

Contact Details

Email Address

Address

86-90 Paul Street,
London, EC2A 4NE,
United Kingdom

Regional Offices

Address

FINDMECURE LTD
86-90 Paul Street
London, EC2A 4NE
United Kingdom

Website

Email address

Phone

Related Content